Covid-19 roundup: With efficacy data in hand, BioNTech talks pricing; Brazil halts Sinovac trial following patient death
On the heels of becoming the first to release Phase III efficacy data for the Covid-19 vaccine it developed with Pfizer, BioNTech is now talking …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
